Beranda › Kanker Mulut › Tennessee › Nashville
Uji klinis Kanker Mulut di Nashville, TN
6 studi untuk Kanker Mulut mencari peserta di lokasi sekitar Nashville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Menerima pesertaFase 2
- Vanderbilt University/Ingram Cancer Center, Nashville
DESTINY-PANTUMOUR04
Menerima pesertaStudi observasional
- Research Site, Nashville
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Menerima pesertaFase 2/3
- Vanderbilt University/Ingram Cancer Center, Nashville
Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Menerima pesertaFase 1
- Vanderbilt University Medical Center, Nashville
Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Menerima pesertaFase 1
- Vanderbilt University Medical Center, Nashville
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Menerima peserta
- Vanderbilt University Medical Center, Nashville
Uji klinis Kanker Mulut di kota lain
- Atlanta, GA9 studi
- St. Louis, MO8 studi
- Chicago, IL8 studi
- New York City, NY8 studi
- Durham, NC7 studi
- Houston, TX7 studi
- Milwaukee, WI7 studi
- Pittsburgh, PA7 studi
- Kansas City, MO7 studi
- Portland, OR7 studi
- Ann Arbor, MI7 studi
- Richmond, VA7 studi
Studi lain di Nashville
- Kanker Paru Non-Sel Kecil97 studi
- Kanker Payudara81 studi
- Kanker Metastatik70 studi
- Kanker Kolorektal69 studi
- Kanker (semua jenis)65 studi
- Kanker Ovarium49 studi
- Kanker Prostat43 studi
- Kanker Paru40 studi
- Karsinoma Sel Skuamosa Kepala dan Leher39 studi
- Kanker Pankreas39 studi
- Kanker Endometrium38 studi
- Melanoma33 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.